Can evidence harm? Certainly not hemophilia treatment and community.
作者信息
Iorio A, Stobart K, Bolton-Maggs P
出版信息
J Thromb Haemost. 2006 Mar;4(3):505-6. doi: 10.1111/j.1538-7836.2006.01853.x.
Abstract
摘要
相似文献
1
Can evidence harm? Certainly not hemophilia treatment and community.
J Thromb Haemost. 2006 Mar;4(3):505-6. doi: 10.1111/j.1538-7836.2006.01853.x.
2
Need for randomized trials in hemophilia.
J Thromb Haemost. 2006 Mar;4(3):501-2. doi: 10.1111/j.1538-7836.2006.01852.x.
3
Are randomized clinical trials the only truth? Not always.
J Thromb Haemost. 2006 Mar;4(3):503-4. doi: 10.1111/j.1538-7836.2006.01841.x.
4
More on: are randomized clinical trials the only truth? Not always.
J Thromb Haemost. 2006 May;4(5):1167-8. doi: 10.1111/j.1538-7836.2006.01938.x.
5
Factor VIII products and inhibitor development: the SIPPET study (survey of inhibitors in plasma-product exposed toddlers).
Haemophilia. 2007 Dec;13 Suppl 5:65-8. doi: 10.1111/j.1365-2516.2007.01580.x.
6
Hemophilia replacement products, clinical trials: inhibitors and pharmacokinetics-can they be done?
J Thromb Haemost. 2004 Oct;2(10):1855-6. doi: 10.1111/j.1538-7836.2004.00911.x.
7
Innovations in coagulation: improved options for treatment of hemophilia A and B.
Thromb Res. 2013 Mar;131 Suppl 2:S1. doi: 10.1016/S0049-3848(13)00051-0.
8
[The use of coagulation factors in hemophilia treatment].
Pharm Unserer Zeit. 2006;35(1):66-73. doi: 10.1002/pauz.200500157.
9
Prophylaxis in congenital coagulation disorders: past, present and future.
Blood Transfus. 2008 Sep;6 Suppl 2(Suppl 2):s1-3. doi: 10.2450/2008.0029-08.
10
A history of prophylaxis in haemophilia.
Blood Coagul Fibrinolysis. 2019 Mar;30(2):55-57. doi: 10.1097/MBC.0000000000000783.
Zotero 插件